EPCAM and neoplasm: To examine T cell activation potential and kinetics mediated by the CD3xEpCAM antibody, freshly isolated OT1 T cells were cocultured with B16/EpCAM tumor cells and analyzed for expression of CD69 and CD44 activation markers(30–32) at 24, 48, and 72 hours (Fig. 2A, B).